Claris Biotherapeutics, Inc.

New Filing
CIK: 0001809726·Biotechnology·DELAWARE·Filed: Aug 7, 2026
Total Offering

$121,477,910

Amount Sold

$55,737,646

Investors

14

First Sale

Nov 25, 2025

Offering Details

Type
Equity, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Stephen Brady
Reza Dana
Kenneth Harrison
Marc de Garidel
Meredith Fisher
Henry Rath
Susan Orr
Michael Dybbs
Matt Hobson
Maha Radhakrishnan
Clarke Atwell
Brian Baum

Company

Claris Biotherapeutics, Inc.

475 MAGELLAN AVE

HALF MOON BAY, CA, 94019

201-344-7638

SEC Filing

0001809726-26-000003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free